Recurrent pregnancy loss in the context of antiphospholipid antibodies: comment on the article by Triolo et al.
Laskin
C A
CA
Clark
C A
CA
Spitzer
K A
KA
D000026:Abortion, Habitual / Q000188:drug therapy* / Q000276:immunology*; D017152:Antibodies, Antiphospholipid / Q000032:analysis*; D001241:Aspirin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D011247:Pregnancy
D017152:Antibodies, Antiphospholipid; D006495:Heparin, Low-Molecular-Weight; D016756:Immunoglobulins, Intravenous; D001241:Aspirin